Clinical trial · Observational
Spectral Precise Image Study for Brain Tumors
Clinical Study for Exploring Image Quality the Spectral Precise Image in Patients With Diagnosed Intracranial Tumors
NCT07620470CI-TRIAL-00113262recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors. The main question it aims to answer is: The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Tumors | Brain Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| This is an observational data collection study | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Subjective Image quality using Likert score (1-5)
- timeFrame
- From date of image reconstruction until the date of image reading completion, anticipated 3Months.
- description
- Image quality will be assessed by 2 radiologists using Likert score on a scale ranging from 1(poor) to 5(Excellent)
- measure
- Objective Image Quality
- timeFrame
- From date of image reconstruction until the date of image reading completion, anticipated 3Months.
- description
- The objective quality of the image is evaluated by measuring the CT value shown in the image.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with clinical and radiology (MRI/CT) diagnosed brain tumors. 2. Patients who underwent contrast enhanced scans using the Spectral CT 7500. 3. Study participants with age ≥ 18 years old. 4. Study participants that have signed Informed Consent Form (ICF) Exclusion Criteria: 1. The clinical data or radiological information is considered incomplete after evaluation by the investigator. 2. Study participant that was enrolled in this study in the past 3. Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation
References
Publications (0)
Data not yet available
No reference posted for this study.